Allergan plc 4
4 · Allergan plc · Filed Apr 4, 2017
Insider Transaction Report
Form 4
Allergan plcAGN
Nicholson C. David
Chief R&D Officer
Transactions
- Award
Ordinary Shares, par value $0.0001
2017-04-03$237.68/sh+8,835$2,099,903→ 16,938 total
Footnotes (2)
- [F1]The reported securities are restricted share units, each of which represents a right to receive one ordinary share of Allergan plc. The restricted share units will vest twenty percent (20%) on April 3, 2018, twenty percent (20%) on April 3, 2019, twenty percent (20%) on April 3, 2020, twenty percent (20%) on April 3, 2021 and twenty percent (20%) on April 3, 2022.
- [F2]Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.